Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2003
03/12/2003EP1289496A1 Carbohydrate medical solution and sulphite stabilisator in a multiple compartment container and use thereof
03/12/2003EP1289495A1 Process for the preparation of a sterile ointment containing acyclovir
03/12/2003EP1289494A2 Powder compositions
03/12/2003EP1289493A1 Pharmaceutical compositions comprising desglymidodrine as an active drug substance
03/12/2003EP1289487A1 Pre-formed sheet devices suitable for topical application
03/12/2003EP1289475A2 Water-thin emulsions with low emulsifier levels
03/12/2003EP1289474A2 Low emulsifier multiple emulsions
03/12/2003EP1289384A2 Aqueous chondroprotective compositions having defined ph limitations for efficacious delivery
03/12/2003EP1289383A1 Primary composition containing a lipophilic bioactive compound
03/12/2003EP1289364A1 Stable gabapentin containing more than 2o ppm of chlorine ion
03/12/2003EP1196034B1 Antiparasitic formulation
03/12/2003EP1191927B1 Microreservoir system on the basis of polysiloxanes and ambiphilic solvents
03/12/2003EP1181018B1 Ziprasidone suspension
03/12/2003EP1137430B1 Therapeutic agent for the suppression of snoring noises
03/12/2003EP1103252B1 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method
03/12/2003EP1077726B1 Inhibiting undesirable taste in oral compositions
03/12/2003EP1041967B1 Microparticles and their therapeutic or diagnostic use
03/12/2003EP1009410B1 Method for producing stable acetylsalicylic acid solutions
03/12/2003EP0999824B1 Release devices
03/12/2003EP0991415B1 Orally administrable solid ribavirin dosage forms and process for making them
03/12/2003EP0984773B1 Pharmaceutical formulation of omeprazole
03/12/2003EP0970705B1 Agglomerate of spherical polyvalent-metal alginate particulates, controlled-release preparation comprising difficultly soluble drug supported on said agglomerate, and processes for producing the both
03/12/2003EP0932396B1 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
03/12/2003EP0869783B1 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
03/12/2003EP0796076A4 N-vinyl lactam polymer containing tablets of low friability and high rate of dissolution
03/12/2003EP0742716B1 Pharmaceutical composition for systemic transdermal administration containing the active agent morphine-6-glucuronide
03/12/2003EP0661969B1 Taxol for treating lymphomas and breast cancer and for reducing multi-drug resistance to taxol
03/12/2003EP0652754B1 Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
03/12/2003CN2539522Y Foam-therapy patch
03/12/2003CN1402797A Compositions and methods for preventing transepithelial transmission of HIV
03/12/2003CN1402778A Elastic article
03/12/2003CN1402768A Pressure sensitive conductive adhesive having hot-melt properties and biomedical electrodes using same
03/12/2003CN1402704A Comminuted form of (S)-2-ethoxy-3-[4-(2-{4-methane-sulfonyloxyphenyl} ethoxy) phenyl] propanoic acid
03/12/2003CN1402642A Solutions and methods for inhibition of pain, inflammation and cartilage degradation
03/12/2003CN1402641A Pharmaceutical compositions of fibrinolytic agent
03/12/2003CN1402640A Stabilized liquid polypeptide-confg. pharmaceutical compositions
03/12/2003CN1402636A Pharmaceutical formulations contg. zolmitriptan
03/12/2003CN1402633A Transdermal therapeutic system with improved stability and method for production thereof
03/12/2003CN1402632A Hydrogel-driven drug dosage form
03/12/2003CN1402631A Extended release formulation of etodolac
03/12/2003CN1402630A Novel pharmaceutical compositions
03/12/2003CN1402629A Pharmaceutical compositions providing enhanced drug concentrations
03/12/2003CN1402616A Addition of tetracyclines to animal foodstuffs
03/12/2003CN1402615A Irreversible coating particles and compositions contg. these particles
03/12/2003CN1401388A Child 'Xuebao' chewing tablet and preparing process thereof
03/12/2003CN1401376A Green tea polyphenol anti-caries coating film
03/12/2003CN1401372A Antiinflammatory hemostatic gynecologic medicine and use thereof
03/12/2003CN1401366A Chinese medicinal herbs ointment and preparing method thereof
03/12/2003CN1401360A Chinese medicine ointment for treating arthrosis
03/12/2003CN1401347A Brain and heart recovery pill
03/12/2003CN1401338A Buccal tablet with pharynx purging and intestine lubricating action
03/12/2003CN1401334A Compound 'Shuanghuanglian' preparation and preparing process thereof
03/12/2003CN1401330A Buccal red deer horn tablet
03/12/2003CN1401325A Pharmaceutical composition
03/12/2003CN1401323A Compound ointment for treating fungous dermatosis
03/12/2003CN1401257A Chewing gum component for eliminating nicotine
03/12/2003CN1102854C Composition for sustained release of human growth hormone
03/12/2003CN1102851C Plasma like solution
03/12/2003CN1102850C Percutaneously absorbable preparation
03/12/2003CN1102847C Medicine or nutrient contg. daidzein material
03/11/2003USRE38027 Preparation of agarose coated, solid agarose-collagen beads containing secretory cells
03/11/2003US6531510 N,N′-bis(2-hydroxybenzyl)ethylenediamine-N,N′-diacetic acid in iron chelating therapy
03/11/2003US6531509 <.5% of a corresponding lactam and > 20 ppm of an anion of a mineral acid, and after one year of storage at 25 degrees C. and 60% humidity conversion to the lactam doesn't exceed .2%
03/11/2003US6531508 Antibacterial medicinal compositions
03/11/2003US6531507 Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
03/11/2003US6531504 Prostanoic acid derivatives as agents for lowering intraocular pressure
03/11/2003US6531500 Treating a skin condition or disease characterized by ulceration, inflammation, or blistering by administering an oil-in-water emulsion comprising: (a) allantoin; and (b) an emulsifier system including beeswax and an anionic emulsifier
03/11/2003US6531471 Morpholinone and morpholine derivatives and uses thereof
03/11/2003US6531458 Stable formulation for oral administration
03/11/2003US6531252 Method of manufacturing a matrix for cathode-ray tube
03/11/2003US6531160 Microcapsules with an aqueous core containing at least one water-soluble cosmetic or dermatological active principle and cosmetic or dermatological compositions containing them
03/11/2003US6531158 Active ingredient's post-ingestion dissolution rate and its corresponding bioavailability can be optimized by intimately mixing a micronized hydrophobic drug with suitably sized inert particles to a dispersion that will facilitate desired
03/11/2003US6531157 The present invention relates to stable emulsions and dry powders of mixtures of fat-soluble vitamins, and to processes for their preparation and to their use.
03/11/2003US6531156 Aqueous solven encapsulation method, apparatus and microcapsules
03/11/2003US6531155 Granular materials obtainable by pressing mixtures of at least one pulverulent, rheology- modifying, carboxyl-containing polymer as main component and at least one oil-soluble component
03/11/2003US6531154 Modulated release from biocompatible polymers
03/11/2003US6531153 Composition with sustained release of levodopa and carbidopa
03/11/2003US6531152 Core comprising: active agent, a core material that swells when exposed to an aqueous liquid, a hardness enhancer, and a disintegrant; rigid, insoluble, pourous coating surrounding said core that disintegrates and bursts when said core swells
03/11/2003US6531151 Tablet, powder or granule of paracetamol or diclofenac and at least one of hydroxypropylmethylcellulose, hydroxypropyl cellulose containing a minimum of 50% of substitution by hydroxypropoxy groups, and ethylcellulose as disintegrants
03/11/2003US6531150 Insolubilization of the gelatin layer is inhibited by addition of a water-soluble gel layer containing an acid or an acid salt thereof present between the gelatin coating layer and the content
03/11/2003US6531149 Treating skin of a human or an animal therapeutically, by applying to said skin said hormone containing patch
03/11/2003US6531147 Compliant tissue sealants
03/11/2003US6531143 α-hydroxy fatty acid derivatives and external compositions containing the same
03/11/2003US6531139 Self-emulsifying formulation for lipophilic compounds
03/11/2003US6531129 Heparanase specific molecular probes and their use in research and medical applications
03/11/2003US6531126 Animal derived lipid
03/11/2003US6531120 Comprising histamine, its receptor analog, serotonin and its receptor analog in an opthalmic solution or gel for reducing irritation due to infection, allergies, pollutants and other irritants in a pharmaceutically acceptable carrier
03/11/2003US6531117 Colloidal dispersion
03/11/2003US6531114 Sildenafil citrate chewing gum formulations and methods of using the same
03/11/2003US6531112 Formulations for administering calcitonin and processes for preparing the same
03/11/2003US6530958 Tissue regeneration matrices by solid free-form fabrication techniques
03/11/2003US6530950 Intraluminal stent having coaxial polymer member
03/11/2003US6530944 Localized delivery of heat and biological imaging materials
03/11/2003US6530901 Portable painkilling system
03/11/2003US6530807 Coaxial connector having detachable locking sleeve
03/11/2003US6530684 Preparation of liquid dispersions
03/11/2003CA2177696C Lipid vesicles containing avocado oil unsaponifiables
03/11/2003CA2109085C Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
03/11/2003CA2020405C Polymer base blend compositions containing destructurized starch
03/06/2003WO2003019182A1 Method for producing microparticles loaded with proteins
1 ... 2169 2170 2171 2172 2173 2174 2175 2176 2177 2178 2179 2180 2181 2182 2183 2184 2185 2186 2187 2188 2189 ... 2991